Drug Profile
R 873
Latest Information Update: 14 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Erectile dysfunction therapies
- Mechanism of Action G protein-coupled receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 19 Oct 2006 Discontinued - Phase-II for Erectile dysfunction in Switzerland (unspecified route)
- 04 Jul 2006 Phase-II clinical trials in Erectile dysfunction in Switzerland (unspecified route)
- 31 Dec 2004 Phase-I clinical trials in Erectile dysfunction in Switzerland (unspecified route)